Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
Ablation of peroxisome proliferator activated receptor (PPAR) alpha, a lipid-activated transcription factor that regulates expression of beta-oxidative genes, results in profound metabolic abnormalities in liver and heart. In the present study we used PPAR alpha knockout (KO) mice to determine whether this transcription factor is essential for regulating fuel metabolism in skeletal muscle. When animals were challenged with exhaustive exercise or starvation, KO mice exhibited lower serum levels of glucose, lactate, and ketones and higher nonesterified fatty acids than wild type (WT) littermates. During exercise, KO mice exhausted earlier than WT and exhibited greater rates of glycogen depletion in liver but not skeletal muscle. Fatty acid oxidative capacity was similar between muscles of WT and KO when animals were fed and only 28% lower in KO muscles when animals were starved. Exercise-induced regulation and starvation-induced regulation of pyruvate-dehydrogenase kinase 4 and uncoupling protein 3, two classical and robustly responsive PPAR alpha target genes, were similar between WT and KO in skeletal muscle but markedly different between genotypes in heart. Real time quantitative PCR analyses showed that unlike in liver and heart, in mouse skeletal muscle PPAR delta is severalfold more abundant than either PPAR alpha or PPAR gamma. In both human and rodent myocytes, the highly selective PPAR delta agonist GW742 increased fatty acid oxidation about 2-fold and induced expression of several lipid regulatory genes, including pyruvate-dehydrogenase kinase 4 and uncoupling protein 3, responses that were similar to those elicited by the PPAR alpha agonist GW647. These results show redundancy in the functions of PPARs alpha and delta as transcriptional regulators of fatty acid homeostasis and suggest that in skeletal muscle high levels of the delta-subtype can compensate for deficiency of PPAR alpha.
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. muoio@duke.edu
Deborah M
DM
Muoio
Paul S
PS
MacLean
David B
DB
Lang
Shi
S
Li
Joseph A
JA
Houmard
James M
JM
Way
Deborah A
DA
Winegar
J Christopher
JC
Corton
G Lynis
GL
Dohm
William E
WE
Kraus
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D004734:Energy Metabolism; D005227:Fatty Acids / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006706:Homeostasis; D006801:Humans; D007473:Ion Channels; D007527:Isoenzymes / Q000378:metabolism; D007659:Ketones / Q000097:blood; D019344:Lactic Acid / Q000097:blood; D008112:Liver Glycogen / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D024101:Mitochondrial Proteins; D018482:Muscle, Skeletal / Q000502:physiology*; D010080:Oxazoles / Q000494:pharmacology; D010084:Oxidation-Reduction; D010805:Physical Conditioning, Animal; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000502:physiology*; D013844:Thiazoles / Q000494:pharmacology; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology*; D014158:Transcription, Genetic; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000071247:Uncoupling Protein 3
D001786:Blood Glucose; D002352:Carrier Proteins; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; C449302:GW 6471; C464800:GW 742; D007473:Ion Channels; D007527:Isoenzymes; D007659:Ketones; D008112:Liver Glycogen; D024101:Mitochondrial Proteins; D010080:Oxazoles; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D014157:Transcription Factors; C000604392:UCP3 protein, human; C000604393:Ucp3 protein, mouse; C000604394:Ucp3 protein, rat; D000071247:Uncoupling Protein 3; D019344:Lactic Acid; D014443:Tyrosine; D011494:Protein Kinases; C403287:pyruvate dehydrogenase kinase 4